Serina Therapeutics (SER) Market Capitalization (2018 - 2026)

Serina Therapeutics has disclosed Market Capitalization across 9 years of filings, most recently posting $31.8 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 49.14% year-over-year to $31.8 million; the TTM figure through Jun 2026 stood at $31.8 million (down 49.14% YoY), while the FY2025 annual figure was $20.6 million, down 44.22% from the prior year.
• Market Capitalization came in at $31.8 million for Q2 2026 at Serina Therapeutics, up from $20.6 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.2 billion in Q2 2023 to a low of $14.8 million in Q4 2023.
• Average Market Capitalization over 5 years is $408.2 million, with a median of $62.5 million recorded in 2025.
• Year-over-year, Market Capitalization slumped 98.02% in 2023 and jumped 148.5% in 2024.
• Over 5 years, Market Capitalization stood at $748.0 million in 2022, then tumbled by 98.02% to $14.8 million in 2023, then soared by 148.5% to $36.9 million in 2024, then tumbled by 44.22% to $20.6 million in 2025, then jumped by 54.57% to $31.8 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $31.8 million in Q2 2026, $20.6 million in Q4 2025, and $56.5 million in Q3 2025.